相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular Pathology of Lung Cancer
James J. Saller et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2022)
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Annabella F. Thomas et al.
CELL DEATH AND DIFFERENTIATION (2022)
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer
James Isaacs et al.
DRUGS (2022)
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Shuai Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Heng Jiang et al.
EXPERIMENTAL EYE RESEARCH (2022)
Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
Nayeong Koo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Strengths and pitfalls of brigatinib in non-small cell lung cancer patients' management
Fabrizio Tabbo et al.
MINERVA MEDICA (2022)
Lung Metastases: Current Surgical Indications and New Perspectives
Giuseppe Mangiameli et al.
FRONTIERS IN SURGERY (2022)
Resveratrol and Prostate Cancer: The Power of Phytochemicals
Nadia Zaffaroni et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis
Loretah Chibaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The roles and regulation of MDM2 and MDMX: it is not just about p53
Alyssa M. Klein et al.
GENES & DEVELOPMENT (2021)
Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway
Yang Zhao et al.
MOLECULAR MEDICINE REPORTS (2021)
The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
Natalie Silk et al.
JOURNAL OF XENOBIOTICS (2021)
Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway
Yueming Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Potential Adverse Effects of Resveratrol: A Literature Review
Abdullah Shaito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma
In-Sung Song et al.
CANCER LETTERS (2018)
Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling
Mohammad Rasheduzzaman et al.
LIFE SCIENCES (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey et al.
CELL DEATH AND DIFFERENTIATION (2018)
Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells
Dong Hwan Kim et al.
ONCOLOGY REPORTS (2017)
Resveratrol as MDR reversion molecule in breast cancer: An overview
Nafiseh Sadat Alamolhodaei et al.
FOOD AND CHEMICAL TOXICOLOGY (2017)
Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression
Fanhua Kong et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2017)
Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells
Rubiceli Medina-Aguilar et al.
ONCOLOGY REPORTS (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Non-small-cell lung cancer
Cesare Gridelli et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells
Jin-Ah Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
In Vitro Genotoxicity Assessment of a Novel Resveratrol Analogue, HS-1793
Min Ho Jeong et al.
TOXICOLOGICAL RESEARCH (2014)
A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells
Dong Hwan Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage
Hongmei Luo et al.
PLOS ONE (2013)
Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
A. R. Neves et al.
CURRENT MEDICINAL CHEMISTRY (2012)
An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression
Seung Hun Jeong et al.
MOLECULES AND CELLS (2012)
Pharmacological Activation of p53 in Cancer Cells
Mohammad Athar et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Effectiveness and Safety of Bevacizumab for Unresectable Non-Small-Cell Lung Cancer A Meta-Analysis
Kun Yang et al.
CLINICAL DRUG INVESTIGATION (2010)
Resveratrol regulates p66Shc activation in HaCaT cells
Gabriella Fabbrocini et al.
EXPERIMENTAL DERMATOLOGY (2010)
A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells
Seung Hun Jeong et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Relationship of Deregulated Signaling Converging onto mTOR with Prognosis and Classification of Lung Adenocarcinoma Shown by Two Independent In silico Analyses
Hiromichi Ebi et al.
CANCER RESEARCH (2009)
Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad?
Philipp Saiko et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses
Lorna Whyte et al.
CANCER RESEARCH (2007)
Identifying the estrogen receptor coactivator PELP1 in autophagosomes
Kazufumi Ohshiro et al.
CANCER RESEARCH (2007)
Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
P Chène
NATURE REVIEWS CANCER (2003)
Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells
Y Schneider et al.
CANCER LETTERS (2000)
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
L Tessitore et al.
CARCINOGENESIS (2000)